Medication for the treatment of opioid use disorders is often an important and necessary component of recovery. One challenge faced by people in recovery, as well as healthcare providers working with patients and caregivers, is how to combat the stigma of using medications to treat opioid use disorders. Attend this webinar to hear an expert in the field navigate difficult conversations surrounding opioid use disorders and discuss strategies to address stigma, dispel myths, and overcome barriers to adherence to medications that assist people in recovery.
At the completion of this knowledge-based activity, participants will be able to:
- Examine data supporting the role of medications in opioid use disorder recovery.
- Discuss the role of medication for people in recovery and consider the pros and cons of each treatment modality.
- Identify strategies on how to effectively address stigma and other barriers to adherence with medications for opioid use disorder.
Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following activity is approved for 1.0 contact hour of CPE credit (0.1 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-18-162-H01-P.
To obtain credit for completing Combating Stigma and Overcoming Barriers to Medication for Opioid Use Disorder (Home Study), watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: June 20, 2018
Expiration date: June 20, 2021
Combating Stigma and Overcoming Barriers to Medication for Opioid Use Disorder (Home Study) is an archived, online educational activity for pharmacists developed by the American Pharmacists Association.
Anita N. Jacobson, PharmD and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association.
There is no fee for current APhA Members. This online educational activity is available exclusively to APhA members for the first 30 days of release, as a free member benefit. Thereafter, non-members can purchase this activity at a cost of $129.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-18-162-H01-P||0.1 CEUs||June 20, 2018 - June 20, 2021|